FDA approves Dexcom’s Stelo, the first over-the-counter continuous glucose monitor
April 14 (ZFJ) — The Food and Drug Administration cleared the Dexcom Stelo Glucose Biosensor System, the first continuous glucose monitor (CGM) approved for use without a prescription in America, for marketing on March 5.
Stelo is an integrated CGM (iCGM) intended for anyone 18 years and older who doesn’t use insulin, such as diabetic individuals treating their condition with oral medications or people without diabetes who want to see how diet and exercise impact their blood sugar levels.